Search

Objective: To compare the safety and effectiveness of minimal access posterior lumbar interbody fusion (MAPLIF) with open posterior lumbar interbody fusion (OPLIF) in patients with spondylolisthesis and radicular pain., Methods: A prospective study was performed of 47 patients with radicular pain resulting from lumbar spondylolisthesis with a slip of less than 50% who underwent either MAPLIF (n = 23) or OPLIF (n = 24). At 12 months after treatment, clinical outcomes were measured using the Short-Form Health Survey 36 and the visual analog score for both leg pain and back pain, and the degree of reduction of spondylolisthesis, restoration of disc height, and presence of fusion were assessed., Results: Both groups were similar in demographic and baseline clinical features. Both exhibited statistically and clinically significant improvements in back pain (OPLIF, 64%; MAPLIF, 78%), and leg pain (88% for both groups). This was corroborated by improvements in social and physical functioning, which were similar for both groups. The reduction of spondylolisthesis and fusion rates were also similar between the 2 groups. MAPLIF patients commenced mobilization sooner, achieved independent mobilization earlier, and had a shorter hospital stay (4 days versus 7 days)., Conclusion: MAPLIF and OPLIF both reduce leg and back pain and restore function to a similar extent. MAPLIF is as effective as OPLIF in reducing the slip in patients with spondylolisthesis of less than 50%. MAPLIF promotes faster recovery and shortens hospital stay.

This retrospective study evaluated the recovery of ankle dorsiflexion (ADF) weakness following decompressive surgery in order to identify factors indicative of a better outcome. Fifty-six consecutive patients with ADF weakness secondary to nerve root compression underwent lumbar decompressive surgery. The demographic features, duration and severity of preoperative ADF weakness, associated radicular pain, as well as the radiological and intraoperative findings were recorded. ADF weakness at the time of initial follow-up at 6 weeks following surgery, and the latest follow-up at a median of 24 months was recorded. The patients had a mean age of 50.5 years with equal numbers of men and women. Acute disc prolapse was the compressive pathology in 88%. Clinical foot drop, defined as an ADF power of <3 by manual testing according to the Medical Research Council classification, was present in 66% of patients on presentation. Grade 3 power was present in 27% of patients and 7% had grade 4 power on presentation. The mean ADF power on presentation was 1.8. This improved to a mean of 3.2 at 6 weeks following surgery (p < 0.0001). A further small improvement in ADF power occurred after 6 weeks following surgery to a power of 3.5 at the latest follow-up (p < 0.0001). The degree of ADF weakness at latest follow-up correlates with the deficit at presentation (p <0.001). Younger patients made a better recovery (p = 0.03). No other significant associations between the demographic or clinical features and the recovery of the weakness could be identified. Thus, decompressive surgery was associated with an early improvement in ADF weakness. Only small improvements take place beyond 6 weeks following surgery. The degree of deficit at presentation is predictive of the extent of recovery. Recovery in ADF strength is more evident in younger patients.

Background. Transforaminal injection of steroids is used to treat lumbar radicular pain. Not known is whether the route of injection or the agent injected is significant. Study Design. A prospective, randomized study compared the outcomes of transforaminal injection of steroid and local anesthetic, local anesthetic alone, or normal saline, and intramuscular injection of steroid or normal saline. Patients and outcome evaluators were blinded as to agent administered. Methods. The primary outcome measure was the proportion of patients who achieved complete relief of pain, or at least 50% relief, at 1 month after treatment. Secondary outcome measures were function, disability, patient-specified functional outcomes, use of other health care, and duration of relief beyond 1 month. Results. A significantly greater proportion of patients treated with transforaminal injection of steroid (54%) achieved relief of pain than did patients treated with transforaminal injection of local anesthetic (7%) or transforaminal injection of saline (19%), intramuscular steroids (21%), or intramuscular saline (13%). Relief of pain was corroborated by significant improvements in function and disability, and reductions in use of other health care. Outcomes were equivalent for patients with acute or chronic radicular pain. Over time, the number of patients who maintained relief diminished. Only some maintained relief beyond 12 months. The proportions of patients doing so were not significantly different statistically between groups. Discussion. Transforaminal injection of steroids is effective only in a proportion of patients. Its superiority over other injections is obscured when group data are compared but emerges when categorical outcomes are calculated. Over time, the proportion of patients with maintained responses diminishes. [ABSTRACT FROM AUTHOR]

Study Design: A prospective, Phase IV, multicenter, randomized study.Objective: The aim of this study was to compare vertebral fusion success rates following posterolateral fusion [(PLF)/posterolateral intertransverse fusion (PITF)] surgery. The surgical procedure combined posterior lumbar interbody fusion (PLIF) and PLF with internal fixation over one or two levels using silicated calcium phosphate (SiCaP) or bone morphogenetic protein (BMP)-2 as graft material in patients with a degenerative disorder of the lumbar spine.Summary Of Background Data: Few controlled trials have evaluated the bone graft materials available to surgeons treating patients with spinal disorders, including degenerative disc disease, spondylolisthesis, and disc herniation.Methods: Following randomization, the surgical procedure consisting of PLIF and PLF with internal fixation over one or two levels was performed using SiCaP or BMP-2. No other osteoconductive/osteoinductive graft materials were permitted. Spinal fusion was assessed radiographically at ≤24 months. Clinical outcomes (pain on visual analog scale, Oswestry Disability Index, SF-36) and adverse events (AEs) were monitored.Results: One hundred three patients were enrolled. At 12 months, fusion was achieved in 25 of 35 (71.4%) of the SiCaP and 20 of 27 (74.1%) of the BMP-2 group, respectively (P = 1.000). At 24 months, the fusion rate was 78.6% and 84.8% for SiCaP and BMP-2, respectively (P = 0.5613). Clinical outcomes improved similarly in both groups over time. AEs were consistent with this surgical population.Conclusion: SiCaP was safe and well tolerated in patients with degenerative spinal disorders requiring PLF and provided fusion rates similar to BMP-2.Level Of Evidence: 2. [ABSTRACT FROM AUTHOR]